PP Influence of sacubitril/ valsartan on biochemical markers in patients with chronic heart failure after COVID-19

被引：0
|
作者：
Minovarova, C. [1 ]
Atadjanova, G. [1 ]
Uzokov, J. [2 ]
Tursunov, J. [3 ]
机构：
[1] Tashkent Paediat Med Inst, Tashkent, Uzbekistan
[2] Republican Specialized Sci Pract Med Ctr Therapy, Tashkent, Uzbekistan
[3] JackSoft Clin, Tashkent, Uzbekistan
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
58ASM - 14
引用
收藏
页数：1
相关论文
共 50 条
  • [1] INFLUENCE OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR ON BIOCHEMICAL MARKERS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER COVID-19
    Sabirova, Guzal
    Uzokov, Jamol
    Usmonxudjaeva, Adiba
    Demin, Nikita
    Jumaeva, Gulruhsor
    ATHEROSCLEROSIS, 2024, 395
  • [2] Influence of angiotensin receptor-neprilysin inhibitors in biochemical markers patients with chronic heart failure after COVID-19
    Guzal, N.
    Mukhamedova, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [3] Sacubitril/valsartan in COVID-19 patients: the need for trials
    Acanfora, Domenico
    Ciccone, Marco Matteo
    Scicchitano, Pietro
    Acanfora, Chiara
    Casucci, Gerardo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (04) : 253 - 254
  • [4] Sacubitril/valsartan improves ventilation stability in patients with chronic heart failure
    Sciarrone, P.
    Borrelli, C.
    Giannoni, A.
    Gentile, F.
    Aimo, A.
    Vergaro, G.
    Emdin, M.
    Passino, C.
    EUROPEAN HEART JOURNAL, 2020, 41 : 935 - 935
  • [5] Influence of sacubitril/valsartan on diastolic parameters in patients with chronic heart failure with reduced ejection fraction
    Uzokov, J.
    Mukhamedova, M. G.
    Narzullaeva, D. S.
    Nosirova, G. A.
    Orziev, D. Z.
    Majidov, I
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (SUPP_1) : I19 - I19
  • [6] Influence of sacubitril/valsartan on hibernating myocardium in patients with chronic heart failure with reduced ejection fraction
    Mukhamedova, M.
    Narzullaeva, D. S.
    Uzokov, J. K.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (SUPP_1) : I7 - I7
  • [7] Sacubitril/Valsartan in hemodialysis patients with heart failure
    Michel, Anne
    Schmid, Andreas
    Burkhalter, Felix
    SWISS MEDICAL WEEKLY, 2021, 151 : 40S - 40S
  • [8] Atrial remodelling in patients affected by chronic heart failure in therapy with sacubitril/valsartan
    Magnesa, Michele
    Mazzeo, Pietro
    Fortunato, Martino
    Mennella, Raffaele
    Tricarico, Lucia
    Correale, Michele
    Croella, Francesca
    Mallardi, Adriana
    Leopizzi, Alessandra
    Ceci, Vincenzo
    Alfieri, Simona
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [9] Atrial remodelling in patients affected by chronic heart failure in therapy with sacubitril/valsartan
    Magnesa, Michele
    Mazzeo, Pietro
    Fortunato, Martino
    Mennella, Raffaele
    Tricarico, Lucia
    Correale, Michele
    Croella, Francesca
    Mallardi, Adriana
    Leopizzi, Alessandra
    Ceci, Vincenzo
    Alfieri, Simona
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [10] What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
    Pellicori, Pierpaolo
    Urbinati, Alessia
    Shah, Parin
    MacNamara, Alexandra
    Kazmi, Syed
    Dierckx, Riet
    Zhang, Jufen
    Cleland, John G. F.
    Clark, Andrew L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 768 - 778
12345